This HTML5 document contains 51 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
n13http://linked.opendata.cz/resource/domain/vavai/projekt/
n4http://linked.opendata.cz/resource/domain/vavai/riv/tvurce/
n16http://linked.opendata.cz/resource/domain/vavai/subjekt/
n8http://linked.opendata.cz/resource/domain/vavai/vysledek/RIV%2F00669806%3A_____%2F11%3A10108620%21RIV12-MZ0-00669806/
n5http://linked.opendata.cz/ontology/domain/vavai/
shttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
n3http://linked.opendata.cz/ontology/domain/vavai/riv/
n2http://linked.opendata.cz/resource/domain/vavai/vysledek/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n7http://linked.opendata.cz/ontology/domain/vavai/riv/klicoveSlovo/
n10http://linked.opendata.cz/ontology/domain/vavai/riv/duvernostUdaju/
xsdhhttp://www.w3.org/2001/XMLSchema#
n18http://linked.opendata.cz/ontology/domain/vavai/riv/jazykVysledku/
n17http://linked.opendata.cz/ontology/domain/vavai/riv/aktivita/
n14http://linked.opendata.cz/ontology/domain/vavai/riv/druhVysledku/
n9http://linked.opendata.cz/ontology/domain/vavai/riv/obor/
n12http://reference.data.gov.uk/id/gregorian-year/

Statements

Subject Item
n2:RIV%2F00669806%3A_____%2F11%3A10108620%21RIV12-MZ0-00669806
rdf:type
n5:Vysledek skos:Concept
rdfs:seeAlso
http://cgp.iiarjournals.org/content/8/3/135.full.pdf+html
dcterms:description
Authors presented a case report of male patient suffering with advanced lung adenocarcinoma exhibiting mutioned genetic abnormalities having got more than 3 years duration of remission on erlotinib therapy. Authors presented a case report of male patient suffering with advanced lung adenocarcinoma exhibiting mutioned genetic abnormalities having got more than 3 years duration of remission on erlotinib therapy.
dcterms:title
Extraordinary response to erlotinib therapy in a patient with lung adenocarcinoma exhibiting KRAS mutation and EGFR amplification Extraordinary response to erlotinib therapy in a patient with lung adenocarcinoma exhibiting KRAS mutation and EGFR amplification
skos:prefLabel
Extraordinary response to erlotinib therapy in a patient with lung adenocarcinoma exhibiting KRAS mutation and EGFR amplification Extraordinary response to erlotinib therapy in a patient with lung adenocarcinoma exhibiting KRAS mutation and EGFR amplification
skos:notation
RIV/00669806:_____/11:10108620!RIV12-MZ0-00669806
n5:predkladatel
n16:ico%3A00669806
n3:aktivita
n17:N n17:O n17:P
n3:aktivity
N, O, P(NR9087)
n3:cisloPeriodika
3
n3:dodaniDat
n12:2012
n3:domaciTvurceVysledku
n4:7709471 n4:4249844 n4:3424944
n3:druhVysledku
n14:J
n3:duvernostUdaju
n10:S
n3:entitaPredkladatele
n8:predkladatel
n3:idSjednocenehoVysledku
199117
n3:idVysledku
RIV/00669806:_____/11:10108620
n3:jazykVysledku
n18:eng
n3:klicovaSlova
EGFR amplification; KRAS mutation; erlotinib; adenocarcinoma; NSCLC
n3:klicoveSlovo
n7:NSCLC n7:erlotinib n7:EGFR%20amplification n7:KRAS%20mutation n7:adenocarcinoma
n3:kodStatuVydavatele
GR - Řecká republika
n3:kontrolniKodProRIV
[0CEC494EC052]
n3:nazevZdroje
Cancer Genomics and Proteomics
n3:obor
n9:FC
n3:pocetDomacichTvurcuVysledku
3
n3:pocetTvurcuVysledku
7
n3:projekt
n13:NR9087
n3:rokUplatneniVysledku
n12:2011
n3:svazekPeriodika
8
n3:tvurceVysledku
Krejčí, M. Minárik, Marek Benešová, Lucie Pešek, Miloš Říčař, Jan Grossmann, Petr Krejčí, Jana
n3:wos
000290634700003
s:issn
1109-6535
s:numberOfPages
4